CleanCap® - optimized co-transcriptional capping for vaccine and therapeutic applications.
Achieve optimal capping results.
Learn More
Now Available:
GMP-Grade N1-Methylpseudouridine-5’-Triphosphate
Accelerate mRNA production with maximum efficiency.
Get Ready to Scale UpWe offer custom plasmid DNA production services, as well as enhanced scale-up manufacturing of CleanCap® mRNA capping solutions and small molecules.
Learn moreTriLink BioTechnologies, part of Maravai LifeSciences, is a CDMO helping life science leaders and innovators overcome challenges in the synthesis and scale-up of nucleic acids, NTPs and mRNA capping analogs with scale-up expertise and unique mRNA production capabilities, including its proprietary CleanCap® mRNA capping technology. TriLink continues to expand its cGMP and general mRNA, oligonucleotide & plasmid manufacturing capacity at its new global headquarters to support therapeutic, vaccine and diagnostic customers.
Achieve optimal capping results.
Learn MoreRobust service offerings, with the phases and support you need to see your project to completion.
Learn MoreContinued innovation promises new and improved mRNA-based therapeutics
Learn MoreCRISPR-engineered universal T cells provide a novel approach to treating cancer
Learn MoreDirected evolution of Cas9 broadens PAM sequence compatibility
Learn MoreThe TriLink Education Center is an innovation resource hub. Read the latest in technical articles, research updates, publications, and more.
Learn More